What sector does Par Drugs And Chem Ltd belong to?

Par Drugs And Chem Ltd operates in the Healthcare sector, specifically the Pharmaceuticals industry, and is listed on the NSE.

What is the current share price of PAR?

As of the latest available quote, PAR traded at ₹140.92. This price is delayed and cached for about 15 minutes.

What is the P/E ratio of PAR?

Par Drugs And Chem Ltd has a price-to-earnings (P/E) ratio of about 13.23. The P/E ratio compares the share price to earnings per share and is most useful when compared with sector peers and the company's own history.

What is the market capitalisation of PAR?

The market capitalisation of Par Drugs And Chem Ltd is approximately ₹173 Cr.

Is Par Drugs And Chem Ltd profitable?

For its latest reported financial year, Par Drugs And Chem Ltd recorded a net profit margin of about 12.50%.

Does PAR pay a dividend?

Par Drugs And Chem Ltd does not currently show a dividend yield in our data.

What is the return on equity (ROE) of PAR?

Par Drugs And Chem Ltd has a return on equity (ROE) of about 9.95%. ROE measures how much profit a company generates relative to shareholders' equity.

What is the 52-week high and low of PAR?

Over the past 52 weeks, PAR has traded between a low of ₹78.05 and a high of ₹180.00.

Par Drugs And Chem Ltd

PAR NSE Healthcare Pharmaceuticals

₹140.92

-0.11%

Delayed · cached 15 min

Fair value analysis

PAR

Par Drugs And Chem Ltd

₹141.08

Close used for this calculation

₹216.40Fair value

Financial DNA Score

Profitability · Returns · Balance Sheet · Efficiency · Growth

53/100

Profitability15/25

Returns11/25

Balance Sheet11/25

Efficiency16/25

Growth11/25

Good

Quality radar

Consensus fair value

₹216.40

Below FV

▲ +53.4% against the close used

Model range ₹53.25 – ₹380.21

The lowest and highest of the models that produced a value. This is the spread of the methods, not a price target.

Price target range & 52-week position

Bear₹53.25Fair value₹216.40Bull₹380.21

FairClose

52-week traded range

52W low ₹78.5852W high ₹168.25

The 52-week range is measured from the stored price history, not estimated.

Valuation summary

Trading below the consensus fair value

Par Drugs And Chem Ltd closed at ₹141.08, 34.8% below the consensus fair value of ₹216.40 drawn from 9 valuation models.

Financial DNA score 53/100 — Good. P/E of 12.0x against the 20x sector multiple the P/E model uses.

Quantitative summary only — not investment advice.

All valuation models

DCF Valuation

₹180.06

+27.6%

Σ[CF×(1+g)^n/(1.10)^n] + TV/(1.10)^10

g=5%, r=10%, tg=3%, n=10yr

Graham Number

₹155.39

+10.1%

√(22.5 × EPS × BVPS)

EPS=10.65, BVPS=100.77

Graham Formula

₹182.95

+29.7%

EPS × (8.5 + 2g) × 6.5 ÷ FD_Rate

g=5%, FD=7%

P/E Fair Value

₹380.21

+169.5%

EPS × 35.7x (sector P/E)

EPS=10.65, Sector P/E=35.7x

Peter Lynch (PEG)

₹53.25

-62.3%

EPS × Growth% (PEG = 1 is fair)

EPS=10.65, g=5%

EV/EBITDA

₹214.07

+51.7%

(EBITDA × 12.5x − Net Debt) ÷ Shares

EBITDA=210M

Book Value (P/B)

₹99.76

-29.3%

BVPS × (ROE−g)÷(r−g) [Justified P/B — RIM-based]

BVPS=100.77, ROE=10%, g=5%, r=10%

Reverse DCF

₹141.08

+0.0%

Solve for g: Price = Σ[EPS×(1+g)^n/(1.10)^n] + TV

Implied: 1.6% | Historical: 5%

Margin of Safety

₹168.49

+19.4%

Avg(DCF, Graham, P/E) × 75% (25% safety buffer)

Avg fair value=224.65, MoS=25%

Computed on September 12, 2026 from the most recent annual report on file and that day's closing price. Where a company has seen its earnings move sharply since its last annual report, this figure will lag the market.

Educational data only. Not a recommendation to buy, sell or hold any security.

Fair value analysis

Consensus fair value

Price target range & 52-week position

Valuation summary

All valuation models

Equity Timer